Request Sample Inquiry
Diabetic Macular Edema Market

Diabetic Macular Edema Market

Diabetic Macular Edema Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

166

Base Year:

2023

Date

Aug - 2024

Format:

PDF XLS PPT

Report Code:

VMR-VMR-2021-0525

Segments Covered
  • By Indication Type By Indication Type diffuse diabetic macular edema, focal diabetic macular edema
  • By Treatment Type By Treatment Type anti-VEGF, corticosteroids, laser photocoagulation therapy, other off-label drugs
  • By Power Consumption By Power Consumption intravitreal injections, intravitreal implants
  • By End User By End User hospitals, specialty clinics, order pharmacies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 4.35 Billion
Revenue 2032Revenue 2032: USD 5.61 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 3.2%
Fastest Growing Region Fastest Growing Region (2024 - 2032) XX
Largest Region Largest Region (2023): XX
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Global Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. Global Diabetic Macular Edema Market - by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. Global Diabetic Macular Edema Market - by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. Global Diabetic Macular Edema Market - by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. Global Diabetic Macular Edema Market - by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. Global Diabetic Macular Edema Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    8. Market comparative analysis
  4. North America Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. North America Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. North America Diabetic Macular Edema Market, by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. North America Diabetic Macular Edema Market, by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. North America Diabetic Macular Edema Market, by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. North America Diabetic Macular Edema Market, by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. North America Diabetic Macular Edema Market, by Country
      1. U.S.
        1. U.S. Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. U.S. Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. U.S. Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. U.S. Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      2. Canada
        1. Canada Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Canada Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Canada Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Canada Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      3. Mexico
        1. Mexico Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Mexico Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Mexico Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Mexico Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
  5. Europe Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Europe Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. Europe Diabetic Macular Edema Market, by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. Europe Diabetic Macular Edema Market, by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. Europe Diabetic Macular Edema Market, by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. Europe Diabetic Macular Edema Market, by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. Europe Diabetic Macular Edema Market, by Country
      1. Germany
        1. Germany Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Germany Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Germany Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Germany Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      2. UK
        1. UK Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. UK Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. UK Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. UK Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      3. France
        1. France Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. France Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. France Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. France Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      4. Spain
        1. Spain Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Spain Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Spain Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Spain Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      5. Italy
        1. Italy Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Italy Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Italy Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Italy Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      6. BENELUX
        1. BENELUX Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. BENELUX Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. BENELUX Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. BENELUX Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      7. Rest of Europe
        1. Rest Of Europe Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Rest Of Europe Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Rest Of Europe Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Rest Of Europe Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
  6. Asia Pacific Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Asia Pacific Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Diabetic Macular Edema Market, by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. Asia Pacific Diabetic Macular Edema Market, by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. Asia Pacific Diabetic Macular Edema Market, by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. Asia Pacific Diabetic Macular Edema Market, by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. Asia Pacific Diabetic Macular Edema Market, by Country
      1. China
        1. China Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. China Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. China Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. China Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      2. Japan
        1. Japan Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Japan Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Japan Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Japan Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      3. India
        1. India Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. India Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. India Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. India Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      4. South Korea
        1. South Korea Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. South Korea Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. South Korea Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. South Korea Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      5. South East Asia
        1. South East Asia Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. South East Asia Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. South East Asia Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. South East Asia Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Rest of Asia Pacific Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Rest of Asia Pacific Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Rest of Asia Pacific Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
  7. Latin America Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Latin America Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. Latin America Diabetic Macular Edema Market, by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. Latin America Diabetic Macular Edema Market, by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. Latin America Diabetic Macular Edema Market, by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. Latin America Diabetic Macular Edema Market, by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. Latin America Diabetic Macular Edema Market, by Country
      1. Brazil
        1. Brazil Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Brazil Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Brazil Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Brazil Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      2. Argentina
        1. Argentina Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Argentina Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Argentina Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Argentina Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      3. Rest of Latin America
        1. Rest of Latin America Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Rest of Latin America Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Rest of Latin America Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Rest of Latin America Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
  8. Middle East & Africa Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Diabetic Macular Edema Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Diabetic Macular Edema Market, by Indication Type
      1. By diffuse diabetic macular edema
      2. By focal diabetic macular edema
    4. Middle East & Africa Diabetic Macular Edema Market, by Treatment Type
      1. By anti-VEGF
      2. By corticosteroids
      3. By laser photocoagulation therapy
      4. By other off-label drugs
    5. Middle East & Africa Diabetic Macular Edema Market, by Power Consumption
      1. By intravitreal injections
      2. By intravitreal implants
    6. Middle East & Africa Diabetic Macular Edema Market, by End User
      1. By hospitals
      2. By specialty clinics
      3. By order pharmacies
    7. Middle East & Africa Diabetic Macular Edema Market, by Country
      1. GCC Countries
        1. GCC Countries Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. GCC Countries Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. GCC Countries Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. GCC Countries Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      2. South Africa
        1. South Africa Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. South Africa Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. South Africa Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. South Africa Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Diabetic Macular Edema Market, By Indication Type
          1. By diffuse diabetic macular edema
          2. By focal diabetic macular edema
        2. Rest of Middle East & Africa Diabetic Macular Edema Market, By Treatment Type
          1. By anti-VEGF
          2. By corticosteroids
          3. By laser photocoagulation therapy
          4. By other off-label drugs
        3. Rest of Middle East & Africa Diabetic Macular Edema Market, By Power Consumption
          1. By intravitreal injections
          2. By intravitreal implants
        4. Rest of Middle East & Africa Diabetic Macular Edema Market, By End User
          1. By hospitals
          2. By specialty clinics
          3. By order pharmacies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Pfizer Inc.
    2. Bayer AG
    3. Bausch & Lomb Incorporated
    4. Allergan Inc.
    5. F. Hoffmann-La Roche Ltd.
    6. Regeneron Pharmaceuticals Inc.
    7. ShahidBeheshti University of Medical Sciences.
    8. Johns Hopkins University
    9. Novartis AG
    10. The National Eye Institute.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Diabetic Macular Edema valued at USD 4.35 Billion in 2023 and is expected to reach USD 5.61 Billion in 2032 growing at a CAGR of 3.2%.

  • The prominent players in the market are Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated, Allergan Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., ShahidBeheshti University of Medical Sciences., Johns Hopkins University, Novartis AG, The National Eye Institute..

  • The market is project to grow at a CAGR of 3.2% between 2024 and 2032.

  • The driving factors of the Diabetic Macular Edema include

  • XX was the leading regional segment of the Diabetic Macular Edema in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy